| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |